SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Eli Lilly and Company Supports the Medical Community's Testimony on the Clinical Utility of Beta-Amyloid Imaging Agents, Such as Amyvid™ (Florbetapir F 18 Injection), During CMS Public Hearing